Investigation of Factors of Anti-aging Medical Checkups Affecting HDL Subfractions-Reference-Cited by-同舟云学术

Investigation of Factors of Anti-aging Medical Checkups Affecting HDL Subfractions

Published:2021-09-10 Issue:5 Volume:48 Page:379-387
ISSN:1347-0086
Container-title:Health Evaluation and Promotion
language:en
Short-container-title:Health evaluation and promotion

Author:

Oda Kanae¹,Kikuchi Emiko¹,Yamada Chizumi²,Ogata Tamae¹,Okuno Chiori²,Shiina Yutaka¹,Urata Nana¹,Yukumatsu Nobunari³,Kishimoto Noriaki¹,Ishii Naoaki⁴,Nishizaki Yasuhiro³

Affiliation:

1. Department of Clinical Health Science, Tokai University School of Medicine

2. Tokai University Tokyo Hospital

3. Tokai University Hospital

4. Department of Health Management, Underguraduate School of Health Study, Tokai University

Publisher

Japan Society of Health Evaluation and Promotion

Subject

Ocean Engineering

Link

https://www.jstage.jst.go.jp/article/jhep/48/5/48_2018-24/_pdf

Reference30 articles.

1. 1) Gordon DJ, Rifkind BM: High-density lipoprotein—the clinical implications of recent studies. New Engl J Med 1989; 321: 1311-16.

2. 2) AIM-HIGH Investigators, Boden WE, Probstfield JL, et al: Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011; 365: 2255-67.

3. 3) Schwartz GG, Olsson AG, Ballantyne CM, et al: Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J 2009; 158(6): 896-901.

4. 4) Camont L, Chapman MJ, Kontush A: Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med 2011; 17(10): 594-603.

5. 5) Ronsein GE, Heinecke JW: Time to ditch HDL-C as a measure of HDL function? Curr Opin Lipidol 2017; 28(5): 414-8.